{"DataElement":{"publicId":"3371436","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Anaplastic Clinical Tumor T Stage","preferredDefinition":"Extent of the primary thyroid anaplastic tumor based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3366342v1.0:3371414v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3366342","version":"1","preferredName":"Thyroid Gland Neoplasm Clinical Anaplastic T Stage","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"3366311v1.0:3366340v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3366311","version":"1","preferredName":"Thyroid Gland Neoplasm","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12400:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7AB2-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3366340","version":"1","preferredName":"Clinical Anaplastic T Stage","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.:(an-ah-PLAS-tik) A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C14144:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anaplastic","conceptCode":"C14144","definition":"A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B785240A-AD50-A514-E040-BB89AD436782","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B785240A-AD61-A514-E040-BB89AD436782","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3371414","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Anaplastic T Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)_A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells._One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3371414v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Thyroid Cancer pT4b Anaplastic Carcinoma TNM Finding v7","ValueMeaning":{"publicId":"3371416","version":"1","preferredName":"Thyroid Cancer pT4b Anaplastic Carcinoma TNM Finding v7","longName":"3371416","preferredDefinition":"Anaplastic carcinoma with gross extrathyroid extension. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT4b Anaplastic Carcinoma TNM Finding v7","conceptCode":"C89153","definition":"Anaplastic carcinoma with gross extrathyroid extension. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AAF1-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AB0A-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Thyroid Cancer pT4a Anaplastic Carcinoma TNM Finding v7","ValueMeaning":{"publicId":"3371418","version":"1","preferredName":"Thyroid Cancer pT4a Anaplastic Carcinoma TNM Finding v7","longName":"3371418","preferredDefinition":"Intrathyroidal anaplastic carcinoma. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer pT4a Anaplastic Carcinoma TNM Finding v7","conceptCode":"C89151","definition":"Intrathyroidal anaplastic carcinoma. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AB17-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AB30-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3371413","version":"1","preferredName":"Thyroid Cancer TNM Finding v7 American Joint Committee on Cancer Anaplastic T Stage Stage","preferredDefinition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3371413v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer TNM Finding v7","conceptCode":"C89145","definition":"A finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system.  Both the histologic diagnosis and the age of the patient are of such importance in the behavior and prognosis of thyroid cancer that these factors are included in this staging system. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Anaplastic","conceptCode":"C14144","definition":"A term used to describe cancer cells that divide rapidly and have little or no resemblance to normal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AAC5-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AAD6-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Clinical T Stage, Anaplastic","type":"Preferred Question Text","description":"Clinical T Stage, Anaplastic","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B8606DF3-ADB7-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}